PAGEInsider
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | May 01 '26 | Option Exercise | 0.00 | 25,255 | 0 | 35,913 | May 04 |
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | Feb 17 '26 | Sale | 243.00 | 32,210 | 7,827,030 | 10,658 | Feb 18 |
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | Feb 17 '26 | Option Exercise | 156.89 | 51,648 | 8,103,281 | 42,868 | Feb 18 |
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | Feb 15 '26 | Option Exercise | 0.00 | 3,196 | 0 | 13,469 | Feb 18 |
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | Oct 17 '25 | Option Exercise | 157.92 | 21,721 | 3,430,180 | 32,379 | Oct 20 |
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | Oct 17 '25 | Sale | 192.71 | 21,721 | 4,185,793 | 10,658 | Oct 20 |
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | Jul 17 '25 | Sale | 163.55 | 19,137 | 3,129,830 | 10,658 | Jul 18 |
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | May 01 '25 | Option Exercise | 0.00 | 25,255 | 0 | 40,797 | May 05 |
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | Feb 15 '25 | Option Exercise | 0.00 | 1,350 | 0 | 15,927 | Feb 18 |
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | May 01 '24 | Option Exercise | 0.00 | 47,510 | 0 | 25,561 | Oct 31 |